| |
| |
|
| Insider
Information: |
Mahoney Michael F |
| Relationship: |
Director |
| City: |
Natick |
| State: |
MA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
3 |
|
| Direct
Shares |
1,694,743 |
|
|
Indirect Shares
|
196,852 |
|
|
| Direct
Value |
$125,826,969 |
|
|
|
Indirect Value
|
$13,985,993 |
|
|
| Total
Shares |
1,891,595 |
|
|
| Total
Value |
$139,812,963 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
1
|
0
|
|
Stock
price went up :
|
1
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
1.0
|
0.0
|
| Percentage
Gain/Loss : |
 1.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Boston Scientific Corp |
BSX |
Chairman, President & ... |
2024-02-18 |
1,673,878 |
2024-02-18 |
176,245 |
Premium* |
|
|
Baxter International Inc |
BAX |
Director |
2023-05-02 |
9,692 |
2023-05-02 |
20,397 |
Premium* |
|
|
CVS/Caremark Corp |
CVS |
Director |
2024-05-02 |
11,173 |
2024-05-02 |
210 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
189 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 3 of 8
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| BSX |
Boston Scientific Corp |
Chairman, President & CEO |
• • – |
2021-01-01 |
4 |
OE |
$0.00 |
$0 |
D/D |
108,797 |
2,069,218 |
0 |
- |
|
| BSX |
Boston Scientific Corp |
Chairman, President & CEO |
• • – |
2021-02-10 |
4 |
A |
$0.00 |
$0 |
D/D |
71,981 |
2,096,908 |
0 |
- |
|
| BSX |
Boston Scientific Corp |
Chairman, President & CEO |
• • – |
2021-02-15 |
4 |
OE |
$0.00 |
$0 |
D/D |
18,457 |
2,083,441 |
0 |
- |
|
| BSX |
Boston Scientific Corp |
Chairman, President & CEO |
• • – |
2021-02-18 |
4 |
OE |
$0.00 |
$0 |
D/D |
16,306 |
2,091,561 |
0 |
- |
|
| BSX |
Boston Scientific Corp |
Chairman, President & CEO |
• • – |
2021-02-21 |
4 |
OE |
$0.00 |
$0 |
D/D |
16,824 |
2,101,153 |
0 |
- |
|
| BSX |
Boston Scientific Corp |
Chairman, President & CEO |
• • – |
2021-02-22 |
4 |
OE |
$0.00 |
$0 |
D/D |
23,175 |
2,116,866 |
0 |
- |
|
| BSX |
Boston Scientific Corp |
Chairman, President & CEO |
• • – |
2021-02-28 |
4 |
OE |
$0.00 |
$0 |
D/D |
18,330 |
2,124,917 |
0 |
- |
|
| BAX |
Baxter International Inc |
Director |
– • – |
2021-05-04 |
4 |
A |
$0.00 |
$0 |
D/D |
1,116 |
2,267 |
0 |
- |
|
| BSX |
Boston Scientific Corp |
Chairman, President & CEO |
• • – |
2021-05-14 |
4 |
GD |
$0.00 |
$0 |
D/D |
34,965 |
2,081,822 |
0 |
- |
|
| BSX |
Boston Scientific Corp |
Chairman, President & CEO |
• • – |
2021-11-12 |
4 |
GD |
$0.00 |
$0 |
D/D |
34,900 |
2,046,922 |
0 |
- |
|
| BSX |
Boston Scientific Corp |
Chairman, President & CEO |
• • – |
2022-01-01 |
4 |
OE |
$0.00 |
$0 |
D/D |
60,635 |
2,107,557 |
0 |
- |
|
| BSX |
Boston Scientific Corp |
Chairman, President & CEO |
• • – |
2022-02-15 |
4 |
OE |
$0.00 |
$0 |
D/D |
18,457 |
2,102,469 |
0 |
- |
|
| BSX |
Boston Scientific Corp |
Chairman, President & CEO |
• • – |
2022-02-17 |
4 |
OE |
$0.00 |
$0 |
D/D |
18,333 |
2,112,616 |
0 |
- |
|
| BSX |
Boston Scientific Corp |
Chairman, President & CEO |
• • – |
2022-02-18 |
4 |
OE |
$0.00 |
$0 |
D/D |
16,307 |
2,120,792 |
0 |
- |
|
| BSX |
Boston Scientific Corp |
Chairman, President & CEO |
• • – |
2022-02-21 |
4 |
OE |
$0.00 |
$0 |
D/D |
16,825 |
2,130,384 |
0 |
- |
|
| BSX |
Boston Scientific Corp |
Chairman, President & CEO |
• • – |
2022-02-28 |
4 |
OE |
$0.00 |
$0 |
D/D |
18,330 |
2,141,252 |
0 |
- |
|
| BAX |
Baxter International Inc |
Director |
– • – |
2022-05-03 |
4 |
A |
$0.00 |
$0 |
D/D |
2,706 |
5,004 |
0 |
- |
|
| BSX |
Boston Scientific Corp |
Chairman, President & CEO |
• • – |
2022-08-30 |
4 |
GD |
$0.00 |
$0 |
D/D |
365,457 |
1,767,665 |
0 |
- |
|
| BSX |
Boston Scientific Corp |
Chairman, President & CEO |
• • – |
2023-01-01 |
4 |
OE |
$0.00 |
$0 |
D/D |
57,791 |
1,825,456 |
0 |
- |
|
| BSX |
Boston Scientific Corp |
Chairman, President & CEO |
• • – |
2023-02-15 |
4 |
OE |
$0.00 |
$0 |
D/D |
18,457 |
1,821,337 |
0 |
- |
|
| BSX |
Boston Scientific Corp |
Chairman, President & CEO |
• • – |
2023-02-16 |
4 |
OE |
$0.00 |
$0 |
D/D |
16,264 |
1,829,415 |
0 |
- |
|
| BSX |
Boston Scientific Corp |
Chairman, President & CEO |
• • – |
2023-02-17 |
4 |
OE |
$0.00 |
$0 |
D/D |
18,333 |
1,840,534 |
0 |
- |
|
| BSX |
Boston Scientific Corp |
Chairman, President & CEO |
• • – |
2023-02-18 |
4 |
OE |
$0.00 |
$0 |
D/D |
16,307 |
1,848,710 |
0 |
- |
|
| BSX |
Boston Scientific Corp |
Chairman, President & CEO |
• • – |
2023-02-21 |
4 |
OE |
$0.00 |
$0 |
D/D |
16,825 |
1,858,302 |
0 |
- |
|
| BAX |
Baxter International Inc |
Director |
– • – |
2023-05-02 |
4 |
A |
$0.00 |
$0 |
D/D |
4,573 |
9,692 |
0 |
- |
|
189 Records found
|
|
Page 3 of 8 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
